Sanofi ADS (SNY) News Nov 18, 2014, 10:20 a.m. MarketWatch

New Post Public Reply Private Reply Replies (0) Message Board

Nov 18, 2014 at 10:20 AM

Sanofi ADS (SNY) News Nov 18, 2014, 10:20 a.m.
MarketWatch News on SNY
If you're looking big pharma, look no further than Actavis 11:34 a.m. Nov. 17, 2014 - The Trading Deck
Medical-bill mess is worse than you thought 5:00 a.m. Nov. 12, 2014 - Richard Eisenberg
Sanofi slumps, Fiat Chrysler rallies: Europe’s big stock movers 12:22 p.m. Oct. 29, 2014 - Sara Sjolin
Sanofi board ousts CEO Viehbacher after clash over strategy 4:25 a.m. Oct. 29, 2014 - William Horobin
Sanofi shares fall 4% after CEO resigns 3:14 a.m. Oct. 29, 2014 - Sara Sjolin
Novartis advances; Sanofi slumps: Europe’s big stock movers 11:59 a.m. Oct. 28, 2014 - Sara Sjolin
Sanofi's profit drops slightly on revamp costs 1:59 a.m. Oct. 28, 2014 - MarketWatch.com
RBS, Lloyds climb; Sanofi slips: Europe’s big stock moves 10:56 a.m. Sept. 11, 2014 - Sara Sjolin
5 companies that will benefit from ALS awareness 6:58 a.m. Aug. 22, 2014 - Jennifer Booton
Skullcandy gains on upgrade,Tesla reverses gains 1:37 p.m. Aug. 12, 2014 - Sue Chang
U.S. small caps lead broad stock-market gains 3:09 p.m. Aug. 11, 2014 - Anora Mahmudova
Kinder Morgan soars, Tesla rallies on upgrade 11:46 a.m. Aug. 11, 2014 - Sue Chang
MannKind shares soar on Sanofi deal; investors ignore earnings report 9:10 a.m. Aug. 11, 2014 - Russ Britt
MannKind shares soar 23% on Sanofi deal over Afrezza 6:04 a.m. Aug. 11, 2014 - Silvia Ascarelli
Sanofi, MannKind to commercialize Afrezza insulin therapy 4:32 a.m. Aug. 11, 2014 - Silvia Ascarelli
Zoetis narrows full-year earnings guidance 7:12 a.m. Aug. 5, 2014 - MarketWatch.com
Sanofi profit jumps 73%; earnings outlook lifted 2:22 a.m. July 31, 2014 - MarketWatch.com
Regeneron shares jump after cholesterol drug meets test goals 10:16 a.m. July 30, 2014 - Russ Britt
Maybe Amazon will unveil a toaster today 7:08 a.m. June 18, 2014 - Marek Fuchs
Merck, Sanofi, Glaxo explore shedding older drugs 4:43 p.m. June 3, 2014 - MarketWatch.com
Loading more headlines...
Advertisement
Other News on SNY
Sanofi: Recent Plunge Is A Buying Opportunity 9:00 a.m. Today - Seeking Alpha
Companies Spending the Most on R&D 8:39 a.m. Today - 247WallSt.com
Amicus Therapeutics' Fabry disease drug candidate improves cardiac health marker 7:31 a.m. Nov. 17, 2014 - Seeking Alpha
CVRs on Lemtrada +135% following approval 7:19 a.m. Nov. 17, 2014 - Seeking Alpha
Amicus Drug Improves Marker of Heart Health in Fabry Patients 10:01 a.m. Nov. 15, 2014 - TheStreet.com
Genzyme's Lemtrada approved by the FDA 9:47 p.m. Nov. 14, 2014 - Seeking Alpha
Significant Changes In Buffett and Berkshire Hathaway Holdings 4:18 p.m. Nov. 14, 2014 - 247WallSt.com
Regeneron Pharmaceuticals Offers More Upside Than Gilead Sciences 9:23 a.m. Nov. 14, 2014 - Seeking Alpha
Hottest Healthcare Stocks Now – CMN PODD ALGN SNY 12:30 p.m. Nov. 11, 2014 - InvestorPlace.com
Actavis Says 'Let's Make A Deal' 9:42 a.m. Nov. 11, 2014 - Seeking Alpha
Sanofi/Regeneron asthma drug successful in Phase 2 trial 7:44 a.m. Nov. 11, 2014 - Seeking Alpha
MannKind Is On The Mend 7:07 p.m. Nov. 7, 2014 - Seeking Alpha
Alnylam Pharmaceuticals Staying Ridiculously Busy 11:25 a.m. Nov. 7, 2014 - Seeking Alpha
Today's Market: Earnings And News Moving These 5 Stocks 10:01 a.m. Nov. 6, 2014 - Seeking Alpha
Regeneron Plunges In What Barron's Calls A Significant Disappointment: My Analysis 8:32 a.m. Nov. 6, 2014 - Seeking Alpha
6 Dividend-Paying Stocks From Around the World 10:34 a.m. Nov. 5, 2014 - Barrons.com
MannKind’s Progress Seen More Gradual 10:25 a.m. Nov. 5, 2014 - Barrons.com
What We Learned From The MannKind 3rd Quarter Conference Call 8:27 a.m. Nov. 5, 2014 - Seeking Alpha
Diabetes Analyst: Sanofi CEO's Firing May Spell Trouble for MannKind Afrezza Partnership 1:40 p.m. Nov. 4, 2014 - TheStreet.com
MannKind Corporation Stock: MNKD Third-Quarter Earnings Takeaways 6:23 a.m. Nov. 4, 2014 - InvestorPlace.com
Loading more headlines...
Press Releases on SNY
Genzyme’s Lemtrada Approved by the FDA 9:00 p.m. Nov. 14, 2014 - BusinessWire - BZX
Regeneron and Sanofi Announce Positive Results from Phase 2b Study of Dupilumab in Patients with Moderate-to-Severe Asthma 1:00 a.m. Nov. 11, 2014 - PR Newswire - PRF
Pharma Stocks on our Radar - Pfizer, Merck, Sanofi, Shire, and Zogenix 8:55 a.m. Nov. 4, 2014 - PR Newswire - PRF
Genzyme Announces Enrollment of First Patient in Phase II Vatelizumab Trial in Relapsing Remitting Multiple Sclerosis 6:00 a.m. Nov. 4, 2014 - BusinessWire - BZX
Sanofi Pasteur Announces FDA Approval of Updated Prescribing Information for Fluzone® High-Dose Vaccine for Adults 65 and Older 8:30 a.m. Nov. 3, 2014 - PR Newswire - PRF
SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Sanofi 9:00 a.m. Oct. 30, 2014 - PR Newswire - PRF
Sanofi: Sanofi Delivers Business EPS Growth of 10.3% at CER 8:34 a.m. Oct. 28, 2014 - PR Newswire - PRF
New International GPCR Consortium Formed with Pharma and Academia to Advance Structural Information about G-protein Coupled Receptors 6:00 a.m. Oct. 28, 2014 - PR Newswire - PRF
Sanofi Q3 2014 Results - Interview with Jérôme Contamine 3:00 a.m. Oct. 28, 2014 - PR Newswire - PRF
Results from Two Phase III Studies Added to U.S. Label of Genzyme’s Aubagio 10:35 a.m. Oct. 20, 2014 - BusinessWire - BZX
US FDA Accepts for Review a Biologics License Application for Merck and Sanofi Pasteur’s Investigational Pediatric Hexavalent Vaccine 8:02 a.m. Oct. 20, 2014 - BusinessWire - BZX
Regeneron and Sanofi Announce Start of Phase 3 Study of Dupilumab in Patients with Atopic Dermatitis 7:00 a.m. Oct. 20, 2014 - PR Newswire - PRF
Sanofi Pasteur and Immune Design Enter Broad Collaboration for the Development of a Herpes Simplex Virus Therapy 8:01 a.m. Oct. 16, 2014 - GlobeNewswire
New Survey Finds Differences In Attitudes About Diabetes Based On Age 8:00 a.m. Oct. 15, 2014 - PR Newswire - PRF
Genzyme Announces Winners of Patient Advocacy Leadership (PAL) Awards 8:00 a.m. Oct. 1, 2014 - BusinessWire - BZX
Regeneron and Sanofi Announce Positive Phase 2 Top-line Dupilumab Results in Patients with Chronic Sinusitis with Nasal Polyps 1:00 a.m. Sept. 30, 2014 - PR Newswire - PRF
Scanning Pharma Equities - Novo Nordisk, Teva Pharma Industries, Sanofi, Valeant Pharma Intl., and Eli Lilly 9:10 a.m. Sept. 26, 2014 - PR Newswire - PRF
Genzyme Collaborates on Gene Therapy for Rare Disease that Causes Childhood Blindness 8:00 a.m. Sept. 24, 2014 - BusinessWire - BZX
Sanofi and MyoKardia Announce Groundbreaking Collaboration to Develop Targeted Therapies for Patients with Genetic Heart Disease 8:34 a.m. Sept. 17, 2014 - PR Newswire - PRF
At Four Years, Treatment Effect Maintained in More Than Two-Thirds of Patients Who Received Genzyme’s Lemtrada in Pivotal Studies 1:00 a.m. Sept. 11, 2014 - BusinessWire - BZX
Loading more headlines...

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Klydoclock's Bold Move: Licensing International Boost

Revolutionizing Timekeeping with Art There’s this clock outfit, Klydoclock, that’s flipping the script on how we see time and art melding together. You see, they’ve taken those static old tick-tock reminders of the hour and juiced 'em up with animated art, turning your wall clock into something more akin to a mini art exhibit right in your living room. Ever heard of...

Primrose Schools App: A Bold Step for Digital Literacy

Primrose Schools Delivers a New Era in Child Education Sitting at a crossroads between the tactile charm of hands-on learning and the inevitable march of digital literacy, Primrose Schools has unveiled something that might just rock the boat in early education: their new Balanced Learning® App. This move by Primrose comes at a crucial time when many parents are...

LifeLabs' AI Program: A Manager's New Toolbox

Management In the Age of AI: New Frontiers Gone are the days when a simple software update meant staying competitive. We're in a new era, folks—one where AI isn't just a handy tool—it's reshaping entire industries. But here's the kicker: all the fancy tech in the world won't do squat without savvy managers who know how to drive adoption. Yup, that's the naked truth,...

J.P. Morgan, Thunes Partner for Global Payment Integration

You don't need a crystal ball to see J.P. Morgan's playing the long game by teaming up with Thunes. In this world, where cash is digital and the reach is global, it's all about speed and scale—brushing elbows with the right partners makes all the difference. Sometimes it's about knowing when to hitch your wagon to a reliable workhorse, especially when global commerce is...

Once Upon a Coconut Supports Breast Cancer Cause

Supporting Breast Cancer Awareness When a coconut water brand shifts to pink, it's not just about changing colors—it's a signal of commitment. Every October, the world paints itself pink to stand against breast cancer, and Once Upon a Coconut is no different. This year, they're diving headfirst into Breast Cancer Awareness Month with their limited-edition pink cans, all...

Janitorial Wages Soar 26.7% Amid High Annual Openings

Janitorial Sector Faces Wage Surge and Employment Shifts Look, if you thought the world of janitorial work was all brooms and mops without a paycheck edge, think again. From 2020 to 2025, wages for janitors and building cleaners didn't just tip-toe up the ladder—they practically sprinted, climbing 26.7%. BLS data laid this one out, with hourly pay shooting from $13.98...

Appy Pie Secures Patent for AI Driven App Building

A New Dawn in App Creation You ever think about a world where creating an app is as straightforward as chatting with an old buddy? Well, that future's knocking at the door, courtesy of Appy Pie. They're ruffling feathers with a shiny new U.S. patent promising just that—apps whipped into shape by a bit of chitchat with their AI-powered platform. It's got folks scratching...

Understanding Criminal Threat Charges in Kansas

The Intricacies of Criminal Threat Cases in Kansas Let's cut straight to it: not all heated exchanges land you in court, but words can slap you with a criminal threat charge in Kansas if mishandled. A simple spat can turn legal nightmare, making it crucial to grasp the nuances of these cases. What sets them apart from other charges is the absence of physical...

HiBy Unveils Cyberpunk 2077 Gaming Audio Line

HiBy Hits the Gaming Scene with Cyberpunk Flair It's a wild world when audio tech and gaming collide outside of the usual suspects. HiBy's latest move is a bold pivot into the gaming universe, launching an audacious collaboration with, of all things, the cybernetic chaos of Cyberpunk 2077. You can almost feel the underlying scrappiness of Night City embedded into a couple...

Hyundai Teases 2027 TUCSON: Global Reveal Imminent

Hyundai Sets the Stage for the 2027 TUCSON Hyundai’s ready to roll out its shiny new set of wheels, the 2027 TUCSON, and boy, they sure know how to make an entrance. Mark your calendars for October 1—it's happening right in the Big Apple, none other than Long Island City. Expect the spotlight to hit at precisely 5:15 p.m. ET, and don't worry if you can't snag a...